Erratum: Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation (AAPS PharmSciTech DOI: 10.1208/s12249-014-0112-0);Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation

AAPS PharmSciTech

Volumn 15, Issue 4, 2014, Pages 834-844

  Wang, Lu ^a   Li, Hongtao ^b   Wang, Shengpeng ^a   Liu, Rong ^b   Wu, Zhisheng ^c   Wang, Chunming ^a   Wang, Yitao ^a   Chen, Meiwan ^a  

^a University of Macau   (Macao)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

antitumor evaluation; apoptosis; berberine hydrochloride; solid lipid nanoparticles

Indexed keywords

BERBERINE; DODECYL SULFATE SODIUM; FLUORESCEIN ISOTHIOCYANATE; HOE 33342; LIPOCORTIN 5; SOLID LIPID NANOPARTICLE; ANTINEOPLASTIC AGENT; DRUG CARRIER; LIPID; NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL FRACTIONATION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; DRUG RELEASE; EXOCYTOSIS; FLOW CYTOMETER; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MCF 7 CELL LINE; MTT ASSAY; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; CELL CYCLE CHECKPOINT; CHEMISTRY; DRUG EFFECTS; HEPG2 CELL LINE; SOLUBILITY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BERBERINE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG CARRIERS; HEP G2 CELLS; HUMANS; LIPIDS; MCF-7 CELLS; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY;

EID: 84905092429     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-014-0158-z     Document Type: Erratum

References (35)

1. Li AR, Zhu Y, Li XN, Tian XJ. Antimicrobial activity of four species of Berberidaceae. Fitoterapia. 2007;78(5):379-81. (Pubitemid 47017609)
2. Guo ZG, Lin Z, Sun RQ, Sun SQ, Wang LQ. Analysis of contents of berberine in Coptis chinensis of Lichuan. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004;26(6):618-21.
3. Zhou H, Mineshita S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J Pharmacol Exp Ther. 2000;294(3):822-9. (Pubitemid 30666829)
4. Iwasa K, Lee DU, Kang SI, Wiegrebe W. Antimicrobial activity of 8-alkyl- and 8-phenyl-substituted berberines and their 12-bromo derivatives. J Nat Prod. 1998;61(9):1150-3. (Pubitemid 28464750)
5. Kupeli E, Kosar M, Yesilada E, Husnu K, Baser C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish berberis species. Life Sci. 2002;72(6):645-57. (Pubitemid 35441232)
6. McCarthy N, Mitchell G, Bilous M, Wilcken N, Lindeman GJ. Triple-negative breast cancer: making the most of a misnomer. Asia Pac J Clin Oncol. 2012;8(2):145-55.
7. Albal MV, Jadhav S, Chandorkar AG. Clinical evaluation of berberine in mycotic infections. Indian J Ophthalmol. 1986;34(1):91-2.
8. Zeng X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed Chromatogr. 1999;13(7):442-4. (Pubitemid 29533134)
9. Derosa G, Maffioli P, Cicero AF. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther. 2012;12(8):1113-24.
10. Lin K, Liu S, Shen Y, Li Q. Berberine attenuates cigarette smoke-induced acute lung inflammation. Inflammation. 2013;2013(1):1-8.
11. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition by berberine of cyclooxygenese-2 transcriptional activity in human colon cancer cells. Ethnopharmacology. 1999;66(2):227-33. (Pubitemid 29307925)
12. Jow SJ, Cha LC. Study on the physical and chemical properties of berberine as related to the biological effects. I. Acid dissociation constant. Yao Xue Xue Bao. 1965;12(9):571-6.
13. Rawat DS, Thakur BK, Semalty M, Semalty A, Badoni P, Rawat MS. Baicalein-phospholipid complex: a novel drug delivery technology for phytotherapeutics. Curr Drug Discov Technol. 2013;10(3):1-9.
14. Oh YJ, Choi G, Choy YB, Park JW, Park JH, Lee HJ, et al. Aripiprazolemontmorillonite: a New organic - inorganic nanohybrid material for biomedical applications. Chemistry. 2013;19(15):4869-75.
15. Parveen R, Ahmad FJ, Iqbal Z, Samim M, Ahmad S. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies. Drug Dev Ind Pharm. 2013;2(1):2-9.
16. Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomedicine. 2012;7(1):1841-50.
17. Liu DY, Luo DF, Ye JT. Study on preparation of ginsenoside-Rd solid lipid nanoparticles. Chin J Hosp Pharm. 2010;30(1):25-30.
18. Ju H, Hao CJ, Yin F, Song LL, Chen CL, Xiao L. Preparation and characterization of curcumin solid lipid nanoparticles. Drug Eval Res. 2010;33(6):420-3.
19. Chen C, Fan T, Jin Y, Zhou Z, Yang Y, Zhu X, et al. Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids. Nanomedicine (London). 2012;8(7):1-16.
20. Cai S, Yang Q, Bagby TR, Forrest ML. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Adv Drug Deliv Rev. 2011;63(10-11):901-8.
21. Priano L, Zara GP, El-Assawy N, Cattaldo S, Muntoni E, Milano E, et al. Baclofen-loaded solid lipid nanoparticles: preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration. Eur J Pharm Biopharm. 2011;79(1):135-41.
22. Silva AC, Gonzalez-Mira E, Garcia ML, Egea MA, Fonseca J, Silva R, et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (Sln): high pressure homogenization versus ultrasound. Colloids Surf B: Biointerfaces. 2011;86(1):158-65.
23. Loredana S, Roberto C, Macrco D, Raffaello S, Germana M, Elisabeta M, et al . Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole-blood mode. Eur J Pharm Sci. 2010;39(5):428-36.
24. Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm. 2007;335(1-2):167-75. (Pubitemid 46482862)
25. Wang S, Chen T, Chen R, Hu Y, Chen M, Wang Y. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Int J Pharm. 2012;430(1-2):238-46.
26. Ahmadian S, Barar J, Saei AA, Fakhree MA, Omidi Y. Cellular toxicity of nanogenomedicine in Mcf-7 cell line: Mtt assay. J Vis Exp. 2009;1(26):1-2.
27. Jin X, Tang S, Chen Q, Zou J, Zhang T, Liu F, et al. Furazolidone induced oxidative DNA damage via up-regulating Ros that caused cell cycle arrest in human hepatoma G2 cells. Toxicol Lett. 2011;201(3):205-12.
28. Jenning V, Thunemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm. 2000;199(2):167-77. (Pubitemid 30236188)
29. Chai YS, Hu J, Lei F, Wang YG, Yuan ZY, Lu X, et al. Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with P53/cyclin D1 and Pi3k/Akt. Eur J Pharmacol. 2013;02(41):44-55.
30. Wang Y, Liu Q, Liu Z, Li B, Sun Z, Zhou H, et al. Berberine, a genotoxic alkaloid, induces Atm-Chk1 mediated G2 arrest in prostate cancer cells. Mutat Res. 2012;734(1-2):20-9.
31. He W, Wang B, Zhuang Y, Shao D, Sun K, Chen J. Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma Qbc939 cells. J Pharmacol Sci. 2012;119(4):341-8.
32. Yan K, Zhang C, Feng J, Hou L, Yan L, Zhou Z, et al. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur J Pharmacol. 2011;661(1-3):1-7.
33. Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma Snu-5 cell line. World J Gastroenterol. 2006;12(1):21-8.
34. Athar M, Chaudhury NK, Hussain ME, Varshney R. Hoechst 33342 induces radiosensitization in malignant glioma cells via increase in mitochondrial reactive oxygen species. Free Radic Res. 2010;44(8):936-49.
35. Jaruga E, Salvioli S, Dobrucki J, Chrul S, Bandorowicz-Pikula J, Sikora E, et al . Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett. 1998;433(3):287-93. (Pubitemid 128369980)